Olynth Ha (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Olynth Ha, is an imidazoline nasal decongestant presented as a nasal spray for topical nasal use. It relieves congestion caused by the common cold, sinusitis and allergic rhinitis in adults and children when appropriate. GNH USA supplies Olynth Ha as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is an imidazoline decongestant that reduces nasal swelling in upper‑respiratory conditions.

- Common cold: alleviates nasal blockage and improves breathing. - Sinusitis: decreases mucosal edema to facilitate sinus drainage. - Allergic rhinitis: reduces nasal congestion associated with allergic inflammation.

Xylometazoline Hydrochloride may cause local and systemic reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Sneezing shortly after application. - Dryness of the nasal mucosa. - Headache. - Bitter taste. - Mild epistaxis.

Serious or Rare Side Effects: - Persistent hypertension. - Severe nasal ulceration. - Rebound congestion with prolonged use. - Allergic dermatitis. - Cardiac arrhythmia in susceptible individuals. - Anaphylactic reaction (rare).

Before using Olynth Ha, consider the following safety measures.

- Age restriction: avoid use in children under 6 years unless directed by a healthcare professional. - Duration limit: do not exceed 3‑5 days of continuous use to prevent rebound congestion. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Pregnancy and lactation: consult a physician before use as safety data are limited. - Drug interactions: inform the prescriber of any concurrent nasal or systemic decongestants. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other medications that affect blood pressure or vascular tone.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Systemic alpha‑adrenergic agonists: additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely):\n- Oral decongestants (e.g., pseudoephedrine): may increase systemic sympathomimetic activity. - Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Nasal corticosteroids: monitor for local irritation when used together.